Overall, continued investigation of CRMP2 phosphorylation should enhance our understanding of neuronal biology and disease, ultimately contributing to the development of novel therapeutic strategies for neurodegenerative disorders and neuropathy. This evidence concerns the gene DPYSL2 and neuropathy.